Prof. Morag Park is a Professor in the Departments of Oncology, Medicine, and Biochemistry. She is a Knight of the Ordre national du Québec, Fellow of the Royal Society of Canada, and the Canadian Academy of Health Sciences, Distinguished James McGill Professor and holds the Diane and Sal Guerrera Chair in Cancer Genetics at McGill University.

Pr. Park received a B.Sc. from the University of Glasgow, a Ph.D. at the Medical Research Council Virology Institute in Scotland and completed postdoctoral training at the National Institutes for Cancer Research in Washington DC, US.

She joined McGill University in 1989, was the Scientific Director of the Institute of Cancer Research for the CIHR (2008-13), co-chair of the Canadian Cancer Research Alliance (2008-2010) and is now Director of the Rosalind and Morris Goodman Cancer Institute (2013-present).

She is a recipient of the Canadian Cancer Society Robert L. Noble Prize (2017), the Quebec Breast Cancer Foundation Grand Prix Scientifique (2019) and the Club de Recherches Cliniques du Québec Michel Sarrazin Award (2021).

Prof. Park is a research leader in receptor tyrosine kinases (RTK) and mechanisms of oncogenic activation of RTKs in human cancers and has pioneered studies of the breast tumour and immune microenvironment in triple negative breast cancer (TNBC). She has more than 270 publications, and an h-index of 88.